Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the stability of artificial cornea manufactured by Aurolab and to assess its visual outcomes.


Clinical Trial Description

The keratoprosthesis, also know as an artificial cornea plays a significant role in combating corneal blindness in patients who are no longer candidates for penetrating keratoplasty.The global incidence of corneal blindness is estimated to be 6-8 million. In India there are approximately 6.8 million cases of unilateral corneal blindness and 1.3 million people with bilateral corneal pathology.

Eligible subjects after getting informed consent will be included in this study. All the subjects will have pre-operative evaluation which includes history, visual acuity, Intraocular pressure (IOP), evaluation of tear film and ultrasound A and B scan. Ocular inflammation will be controlled prior to surgery. Keratoplasty will be performed with keratoprosthesis under local anesthesia. Patients will be followed up at regular interval to assess the outcome variables. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01018888
Study type Interventional
Source Aurolab
Contact Mr.Karthikumar S, M.Pharm
Phone 0452-3096100
Email crd@aurolab.com
Status Recruiting
Phase Phase 4
Start date August 2010
Completion date July 2014

See also
  Status Clinical Trial Phase
Recruiting NCT01206127 - DSAEK- Postoperative Positioning and Transplant Dislocation N/A
Terminated NCT00764582 - Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery Phase 4
Recruiting NCT05870566 - Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision] N/A
Recruiting NCT02084745 - Timing of Glaucoma Drainage Device With Boston Keratoprosthesis N/A
Unknown status NCT00834782 - Comparison of DCT, ORA and GAT in Eyes After Penetrating Keratoplasty Phase 4
Withdrawn NCT00345020 - Deep Lamellar Endothelial Keratoplasty: Small Incision Technique
Completed NCT00000137 - Collaborative Corneal Transplantation Studies (CCTS) Phase 3
Recruiting NCT04339907 - Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears) N/A
Active, not recruiting NCT00874835 - Corneal Endothelium Delivery Instrument Phase 2
Completed NCT00570648 - A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization N/A
Enrolling by invitation NCT03461978 - Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures N/A
Not yet recruiting NCT05210478 - Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea
Completed NCT01694914 - Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium Phase 3
Completed NCT03381794 - The German Keratoplasty Registry of the German Ophthalmological Society (DOG) N/A
Recruiting NCT03105466 - Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea N/A
Completed NCT00409656 - Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients Phase 2
Recruiting NCT04490902 - Clinical Study on the Treatment of Mixed Component Cornea for High Risk Keratoplasty N/A
Recruiting NCT04337944 - Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo) N/A
Completed NCT01547975 - Retrospective Analysis of Surgical Outcomes After Corneal Transplantation N/A
Terminated NCT00447642 - Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty Phase 3